1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride
TL;DR: 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride (CAS 107707-39-1) is a chemical compound with molecular formula C18H22Cl4N4O and molecular weight 450.05 g/mol, supplied by Kehong Biological (Henan Kehong Biological Technology Co., Ltd.) with CRO/CDMO custom synthesis services.
N'-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)piperazine-1-carboximidamide;dihydrochloride
Also Known As: 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride, N'-(3,5-Dichlorophenyl)-4-(2-methoxyphenyl)-1-piperazinecarboximidamide dihydrochloride, N'-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)piperazine-1-carboximidamide dihydrochloride, N'-(3,5-Dichlorophenyl)-4-(2-methoxyphenyl)piperazine-1-carboximidamide--hydrogen chloride (1/2), RefChem:233552
| Molecular Formula | C18H22Cl4N4O |
|---|---|
| Molecular Weight | 450.05 g/mol |
| LogP | 4.614 |
| Topological Polar Surface Area | 54.09 Ų |
| Hydrogen Bond Donors | 1 |
| Hydrogen Bond Acceptors | 3 |
| Rotatable Bonds | 3 |
| Exact Mass | 450.05478 |
| Heavy Atoms | 27 |
| Complexity | 759.457 |
Chemical Identifiers
| CAS Number | 107707-39-1 |
|---|---|
| SMILES | COC1=CC=CC=C1N2CCN(CC2)C(=NC3=CC(=CC(=C3)Cl)Cl)N.Cl.Cl |
Product Overview
1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride (CAS 107707-39-1), with molecular formula C18H22Cl4N4O and molecular weight 450.05 g/mol. IUPAC: N'-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)piperazine-1-carboximidamide;dihydrochloride.
Chemical Property Profile of 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride
Property Insights of 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride
The XLogP value of 4.614 indicates that 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride is lipophilic (fat-soluble), which may influence its absorption, distribution, and formulation strategy. With a topological polar surface area (TPSA) of 54.09 Ų, 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride exhibits relatively low polarity, potentially indicating favorable cell membrane permeability. Following Lipinski's Rule of Five, 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride has 1 hydrogen bond donor(s) and 3 hydrogen bond acceptor(s), all within the drug-like range, suggesting favorable oral bioavailability potential.
Frequently Asked Questions
Frequently Asked Questions
What is the CAS number of 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride?
The CAS number of 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride is 107707-39-1.
What is the molecular formula of 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride?
The molecular formula of 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride is C18H22Cl4N4O.
What is the molecular weight of 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride?
The molecular weight of 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride is 450.05 g/mol.
Where can I buy 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride?
You can request a quote for 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride directly from KEHONG BIO. Contact us or email info@kehongbio.com for pricing and availability.
Does KEHONG BIO offer custom synthesis for 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride?
Yes, KEHONG BIO provides custom synthesis services for 1-Piperazinecarboximidamide, N-(3,5-dichlorophenyl)-4-(2-methoxyphenyl)-, dihydrochloride and related compounds. Contact us with your specific requirements including quantity, purity, and timeline.